Članki z zahtevami za javni dostop - Valentina Kutyifa MD PhDVeč o tem
Ni na voljo nikjer: 8
The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause–aims, function and structure: Position paper of the Association for Acute …
C Sinning, I Ahrens, A Cariou, F Beygui, L Lamhaut, S Halvorsen, ...
European Heart Journal: Acute Cardiovascular Care 9 (4_suppl), S193-S202, 2020
Zahteve: British Heart Foundation
Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology
KL Thomas, LT Sullivan II, SM Al-Khatib, NA LaPointe, S Sears, ...
American heart journal 220, 59-67, 2020
Zahteve: Patient-Centered Outcomes Research Institute
Identification of Low‐Risk Adult Congenital LQTS Patients
C Zhang, V Kutyifa, S Mcnitt, W Zareba, I Goldenberg, AJ Moss
Journal of Cardiovascular Electrophysiology 26 (8), 853-858, 2015
Zahteve: US National Institutes of Health
Low blood pressure threshold for adverse outcomes during left ventricular assist device support
H Vidula, O Altintas, S McNitt, AD DeVore, EY Birati, MV Genuardi, ...
The American Journal of Cardiology 169, 78-85, 2022
Zahteve: US National Institutes of Health, American Heart Association, Patient …
Effect of novel programming on inappropriate implantable cardioverter-defibrillator therapy in patients with very low ejection fraction (from A MADIT-RIT)
A Jawaid, M Chokshi, W Zareba, C Schuger, J Daubert, S McNitt, J Singh, ...
The American Journal of Cardiology 182, 32-39, 2022
Zahteve: US National Institutes of Health
Effectiveness of high rate and delayed detection ICD programming by race: A MADIT‐RIT substudy
LR Jackson, KL Thomas, B Polonsky, W Zareba, M Lahiri, S Saba, ...
Journal of cardiovascular electrophysiology 29 (10), 1418-1424, 2018
Zahteve: US National Institutes of Health
Cardiac Resynchronization Therapy for Chemotherapy-Induced Cardiomyopathy—Reply
JP Singh, MG Fradley, V Kutyifa
JAMA 323 (13), 1317-1317, 2020
Zahteve: US National Institutes of Health, US Department of Veterans Affairs
Device therapy: Saving lives with appropriate ICD therapy in elderly patients
V Kutyifa, AJ Moss
Nature Reviews Cardiology 12 (9), 504, 2015
Zahteve: US National Institutes of Health
Na voljo nekje: 67
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
MK Chung, KK Patton, CP Lau, ARJ Dal Forno, SM Al-Khatib, V Arora, ...
Heart rhythm 20 (9), e17-e91, 2023
Zahteve: US National Institutes of Health
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
C Linde, MG Bongiorni, U Birgersdotter-Green, AB Curtis, I Deisenhofer, ...
Ep Europace 20 (10), 1565-1565ao, 2018
Zahteve: British Heart Foundation
Machine learning‐based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy
M Cikes, S Sanchez‐Martinez, B Claggett, N Duchateau, G Piella, ...
European journal of heart failure 21 (1), 74-85, 2019
Zahteve: US National Institutes of Health, Banking Foundation "la Caixa", Government …
Apixaban for stroke prevention in subclinical atrial fibrillation
JS Healey, RD Lopes, CB Granger, M Alings, L Rivard, WF McIntyre, ...
New England Journal of Medicine 390 (2), 107-117, 2024
Zahteve: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Management of asymptomatic arrhythmias: a European heart rhythm association (EHRA) consensus document, endorsed by the heart failure association (HFA), heart rhythm society …
DO Arnar, GH Mairesse, G Boriani, H Calkins, A Chin, A Coats, ...
Ep Europace 21 (6), 844-845, 2019
Zahteve: National Health and Medical Research Council, Australia
Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score
M Tokodi, WR Schwertner, A Kovács, Z Tősér, L Staub, A Sárkány, ...
European heart journal 41 (18), 1747-1756, 2020
Zahteve: National Office for Research, Development and Innovation, Hungary
Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score
A Younis, JJ Goldberger, V Kutyifa, W Zareba, B Polonsky, H Klein, ...
European heart journal 42 (17), 1676-1684, 2021
Zahteve: US National Institutes of Health
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on …
JC Nielsen, YJ Lin, MJ de Oliveira Figueiredo, A Sepehri Shamloo, A Alfie, ...
Ep Europace 22 (8), 1147-1148, 2020
Zahteve: US National Institutes of Health, American Heart Association, German …
Cybersecurity for cardiac implantable electronic devices: what should you know?
A Baranchuk, MM Refaat, KK Patton, MK Chung, K Krishnan, V Kutyifa, ...
Journal of the American College of Cardiology 71 (11), 1284-1288, 2018
Zahteve: US National Institutes of Health
Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial
W Zareba, JP Daubert, CA Beck, DT Huang, JD Alexis, MW Brown, ...
Journal of the American College of Cardiology 72 (6), 636-645, 2018
Zahteve: US National Institutes of Health
Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure …
V Kutyifa, L Geller, P Bogyi, E Zima, MK Aktas, EE Ozcan, D Becker, ...
European journal of heart failure 16 (12), 1323-1330, 2014
Zahteve: Hungarian Scientific Research Fund
Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With …
MH Ruwald, A Abu-Zeitone, C Jons, AC Ruwald, S McNitt, V Kutyifa, ...
Journal of the American College of Cardiology 62 (15), 1343-1350, 2013
Zahteve: US National Institutes of Health
Podatke o objavi in financiranju samodejno določi računalniški program